Saladax Biomedical Inc.
Records under this name other than the patents Saladax Biomedical Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Saladax Biomedical Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,767,794 | 5-fluoro-uracil immunoassay Term ended Term ended Jun 7, 2026 · USPTO record | Term ended | Term ended Jun 7, 2026 | USPTO record |
| US 7,300,768 | Enzymatic measurement of imatinib mesylate Term ended Term ended Nov 14, 2025 · USPTO record | Term ended | Term ended Nov 14, 2025 | USPTO record |
| US 7,423,131 | Busulfan immunoassay Term ended Term ended Nov 6, 2025 · USPTO record | Term ended | Term ended Nov 6, 2025 | USPTO record |
| US 7,148,024 | Busulfan immunoassay Term ended Term ended Sep 13, 2025 · USPTO record | Term ended | Term ended Sep 13, 2025 | USPTO record |
| US 7,276,347 | Cytoxan antibodies and immunoassay Term ended Term ended May 20, 2025 · USPTO record | Term ended | Term ended May 20, 2025 | USPTO record |
| US 8,440,796 | Lenalidomide and thalidomide immunoassays Lapsed on the fee record Ended May 14, 2025 · USPTO record | Lapsed on the fee record | Ended May 14, 2025 | USPTO record |
| US 8,426,143 | Gemcitabine immunoassay Lapsed on the fee record Ended Apr 23, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | USPTO record |
| US 7,459,281 | Docetaxel immunoassay Term ended Term ended Apr 13, 2025 · USPTO record | Term ended | Term ended Apr 13, 2025 | USPTO record |
| US 7,205,116 | 5-Fluoro-uracil immunoassay Term ended Term ended Feb 8, 2025 · USPTO record | Term ended | Term ended Feb 8, 2025 | USPTO record |
| US 7,175,993 | Taxol immunoassay Term ended Term ended Jan 27, 2025 · USPTO record | Term ended | Term ended Jan 27, 2025 | USPTO record |